Genetic Leap is a clinical-stage biotech company innovating at the cutting edge of AI and RNA genetic medicine for in vivo reprogramming with oral medicines to address the health needs of millions of people living with diseases that modern medicine has been powerless against, until now.  

RNA is the central orchestrator of biology. Genetic Leap’s AI platform is proven to successfully reprogram RNA at its sequence using oligonucleotides or at its structure using small molecules, enabling a new generation of powerful, safe, and efficacious drugs.